Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03164317
Other study ID # CCDC-2017-001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 20, 2018
Est. completion date March 31, 2021

Study information

Verified date July 2021
Source Centre for Chronic Disease Control, India
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the effect of a mobile health technology enabled trained nurse led intervention on control of blood pressure among patients with hypertension seeking care in the community health centres in the southern state of Andhra Pradesh, India. half the community health centres will receive the intervention and the other half will receive the routine care.


Description:

The burden of hypertension is very high in India but the control rates of hypertension are very low. One of the important reasons for this is the lack of awareness and the inability of the doctors working in busy out patient settings of public health facilities to care adequately for the patients. Hence there is a need for task shifting. In this trial a trained nurse care coordinator will be placed in the Community Health Centres (CHCs) and she will be provided with an Electronic Decision Support System (EDSS), in the form of an android application installed on a tablet, to treat hypertension. The trial will be carried out in twelve CHCs of Visakhapatnam district in southern Indian state of Andhra Pradesh.


Recruitment information / eligibility

Status Completed
Enrollment 1872
Est. completion date March 31, 2021
Est. primary completion date March 26, 2021
Accepts healthy volunteers No
Gender All
Age group 30 Years and older
Eligibility Inclusion Criteria: 1. Participants aged =30 years. 2. Willing to provide written informed consent for the study. 3. Identified as suffering from hypertension (=160/100 mmHg) with or without co-morbidities such as left ventricular hypertrophy, heart failure, coronary artery disease, peripheral vascular disease, or diabetes mellitus Exclusion Criteria: 1. Participants aged <30years 2. Unwilling/unable to provide written informed consent for the study 3. Having malignancies or life threatening conditions 4. Currently participating in other clinical trials 5. Those with plans to move residence in the year ahead.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Intervention
A trained nurse care coordinator enabled with a electronic decision support system placed at the CHCs to share the task of management of hypertension.
Control
No NCC or EDSS will be placed in the CHCs. Doctors working in the CHCs will be given training (one day) on evidence based management of hypertension

Locations

Country Name City State
India Community Health Centre Aganampudi Andhra Pradesh
India Area Hospital Anakapalli Andhra Pradesh
India Community Health Centre Araku Andhra Pradesh
India Community Health Centre Bhimili Andhra Pradesh
India Community Health Centre Chintapalli Andhra Pradesh
India Community Health Centre Chodavaram Andhra Pradesh
India Community Health Centre K Kotpadu Andhra Pradesh
India Community Health Centre Kotavaratla Andhra Pradesh
India Community Health Centre Nakkapalli Andhra Pradesh
India Community Health Centre Paderu Andhra Pradesh
India Community Health Centre V Madugula Andhra Pradesh
India Community Health Centre Yelamanchili Andhra Pradesh

Sponsors (3)

Lead Sponsor Collaborator
Centre for Chronic Disease Control, India All India Institute of Medical Sciences, New Delhi, Indian Council of Medical Research

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in the mean systolic blood pressure Difference in the mean systolic blood pressure between the intervention and control arm at the end of the intervention 12 months
Secondary Compliance to therapy Difference in compliance to therapy from baseline to one year between the intervention and control arm 12 months
Secondary Follow up with the physician Difference in follow up rate from baseline to one year between the intervention and control arm 12 months
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A